{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:57:10Z","timestamp":1761947830815},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":1475,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vhri.2012.10.001","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T01:07:59Z","timestamp":1355360879000},"page":"129-135","source":"Crossref","is-referenced-by-count":9,"title":["An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System"],"prefix":"10.1016","volume":"1","author":[{"given":"Carine Raquel","family":"Blatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemia Liege Maria da Cunha","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junior Andre","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Fernandes","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Balbinotto Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareni","family":"Rocha Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2012.10.001_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12927\/whp.2006.17869","article-title":"Brazil's fight against AIDS and its implications for global health governance","volume":"8","author":"Wogart","year":"2006","journal-title":"World Health Popul"},{"key":"10.1016\/j.vhri.2012.10.001_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/S0104-42302007000600013","article-title":"Cost estimates of chronic hepatitis B virus for the Brazilian unified health system in 2005","volume":"53","author":"Castelo","year":"2007","journal-title":"Rev Assoc Med Bras"},{"issue":"Suppl. 1","key":"10.1016\/j.vhri.2012.10.001_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1590\/S1413-86702007000700002","article-title":"Epidemiological aspects of hepatitis C in Brazil","volume":"11","author":"Diament","year":"2007","journal-title":"Brazilian J Infect Dis"},{"key":"10.1016\/j.vhri.2012.10.001_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/jhep.2000.19347","article-title":"Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C","volume":"32","author":"Poynard","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.vhri.2012.10.001_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.20941","article-title":"Trends in health care resource use for hepatitis C virus infection in the United States","volume":"42","author":"Grant","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.vhri.2012.10.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11110","article-title":"Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation","volume":"11","author":"Shepherd","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vhri.2012.10.001_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1590\/S0034-89102009005000041","article-title":"Ministry of Health's spending on drugs: program trends from 2002 to 2007","volume":"43","author":"Vieira","year":"2009","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vhri.2012.10.001_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0034-89102011000200001","article-title":"Exceptional circumstance drug dispensing: history and expenditures of the Brazilian Ministry of Health","volume":"45","author":"Carias","year":"2011","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vhri.2012.10.001_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"issue":"10, Suppl.","key":"10.1016\/j.vhri.2012.10.001_bib10","first-page":"S296","article-title":"Treatment issues with chronic hepatitis C: special populations and pharmacy strategies","volume":"11","author":"Bacon","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vhri.2012.10.001_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/gast.2002.35950","article-title":"Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C","volume":"123","author":"McHutchison","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vhri.2012.10.001_bib12","doi-asserted-by":"crossref","unstructured":"Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130:231\u201364, quiz 14\u20137.","DOI":"10.1053\/j.gastro.2005.11.010"},{"key":"10.1016\/j.vhri.2012.10.001_bib13","unstructured":"Blatt CR. Um olhar sobre a efetividade e custos do tratamento da hepatite C sob a perspectiva do Sistema \u00danico de Sa\u00fade [Tese]. Florian\u00f3polis: Universidade Federal de Santa Catarina, 2011."},{"key":"10.1016\/j.vhri.2012.10.001_bib14","unstructured":"Brasil. Portaria n\u00ba 34, de 28 de setembro de 2007. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas - hepatite viral C. Bras\u00edlia, DF: 28 de setembro de 2007, 2007."},{"key":"10.1016\/j.vhri.2012.10.001_bib15","unstructured":"Bernardo NLMdC. Oportunidade de interven\u00e7\u00e3o farmac\u00eautica no tratamento de pacientes com hepatite viral C cr\u00f4nica: estudo de caso no munic\u00edpio de Itaja\u00ed\/SC. [Disserta\u00e7\u00e3o]. Florian\u00f3polis: Programa de Pos-Gradua\u00e7\u00e3o em Farm\u00e1cia, 2010."},{"key":"10.1016\/j.vhri.2012.10.001_bib16","unstructured":"Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS - Sigtap [database on the Internet]. 2010. Available from: http:\/\/sigtap.datasus.gov.br\/tabela-unificada\/app\/sec\/inicio.jsp. [Accessed June 9, 2010]."},{"key":"10.1016\/j.vhri.2012.10.001_bib17","unstructured":"Brasil. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite Viral C e coinfec\u00e7\u00f5es. In: Sa\u00fade Md, ed. S\u00e9ria A ed. Bras\u00edlia: Secret\u00e1ria de Vigil\u00e2ncia em Sa\u00fade, 2011."},{"key":"10.1016\/j.vhri.2012.10.001_bib18","unstructured":"Rosa J.A.D. Tratamento de pacientes com hepatite cr\u00f4nica pelo v\u00edrus C: A experi\u00eancia do P\u00f3lo de Aplica\u00e7\u00e3o e Monitoramento de Medicamentos Injet\u00e1veis do Hospital Nereu Ramos de 2005 a 2008. [Disserta\u00e7\u00e3o]. Florian\u00f3polis: Universidade Federal de Santa Catarina, 2009."},{"key":"10.1016\/j.vhri.2012.10.001_bib19","unstructured":"Convers\u00e3o de moedas do Banco do Brasil [database on the Internet]. 2010. Available from: http:\/\/www4.bcb.gov.br\/pec\/conversao\/Resultado.asp?idpai=convmoeda. [Accessed June 9, 2010]."},{"key":"10.1016\/j.vhri.2012.10.001_bib20","unstructured":"Brasil. Boletim Epidemiol\u00f3gico \u2013 Hepatites Virais. 2010;Ano I - n\u00b0 1."},{"key":"10.1016\/j.vhri.2012.10.001_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2009.01147.x","article-title":"Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C","volume":"17","author":"Sroczynski","year":"2010","journal-title":"J Viral Hepat"},{"issue":"2, Suppl.","key":"10.1016\/j.vhri.2012.10.001_bib22","first-page":"S30","article-title":"Managing hepatitis C","volume":"10","author":"Bacon","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vhri.2012.10.001_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/bmj.332.7548.1013","article-title":"Diagnosis and treatment of chronic hepatitis C infection","volume":"332","author":"Patel","year":"2006","journal-title":"BMJ"},{"issue":"5, Suppl. 1","key":"10.1016\/j.vhri.2012.10.001_bib24","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1053\/jhep.2002.36810","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.vhri.2012.10.001_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1572-0241.2007.01139.x","article-title":"Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy","volume":"102","author":"McHutchison","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vhri.2012.10.001_bib26","unstructured":"National Institutes of Health. Consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements 2002;19:1\u201346."},{"key":"10.1016\/j.vhri.2012.10.001_bib27","first-page":"3","article-title":"Aten\u00e7\u00e3o Farmac\u00eautica no Sistema \u00danico de Sa\u00fade: um exemplo de experi\u00eancia bem sucedida com pacientes portadores de hepatite C","volume":"87","author":"Amaral","year":"2006","journal-title":"Rev Bras Farm"},{"key":"10.1016\/j.vhri.2012.10.001_bib28","first-page":"172","article-title":"Antiviral treatment initiation costs in chronic hepatitis C","volume":"54","author":"Siebert","year":"2005","journal-title":"Gut"},{"issue":"10, Suppl.","key":"10.1016\/j.vhri.2012.10.001_bib29","first-page":"S286","article-title":"Chronic hepatitis C: an age wave of disease burden","volume":"11","author":"McHutchison","year":"2005","journal-title":"Am J Manag Care"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109912000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109912000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:21:09Z","timestamp":1540020069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109912000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S2212109912000702"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2012.10.001","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}